Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/13/2003WO2003044212A3 Nucleic acids and polypeptides of invertebrate brca2 and methods of use
11/13/2003WO2003043565A3 Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
11/13/2003WO2003042244A3 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003040372A3 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
11/13/2003WO2003033463A3 Multimerized enhancer domains for cell-specific expression
11/13/2003WO2003031942A8 Reagents and methods useful for detecting diseases of the breast
11/13/2003WO2003031621A3 A human g protein coupled receptor
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003029404A3 MAST CELL RasGRP4 COMPOSITIONS AND RELATED METHODS
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003023003A3 Nucleic acid-associated proteins
11/13/2003WO2003014157A3 Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003012096A3 Plant stress regulated genes
11/13/2003WO2003008557A3 Activators of cyclin-dependent kinases
11/13/2003WO2003007886A3 Plant ion channels and methods
11/13/2003WO2003006606A3 Targeted fusion proteins and methods for the characterization of cellular membrane domains
11/13/2003WO2003000918A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
11/13/2003WO2003000889A3 Identification of ses-1 and the uses of the same
11/13/2003WO2003000733A3 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003WO2002098443A3 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
11/13/2003WO2002098358A3 Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003WO2002095056A3 A novel g protein-coupled receptor, gave1
11/13/2003WO2002094867A3 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/13/2003WO2002092831A3 Method for identifying ligands for g protein coupled receptors
11/13/2003WO2002090549A3 Compositions and methods for the modulation of viral maturation
11/13/2003WO2002079402A3 Method of inhibiting cancerous cell proliferation using ras mutants of gdp-bound conformation
11/13/2003WO2002079252A8 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
11/13/2003WO2002079243A3 Gonococcal proteins and nucleic acids
11/13/2003WO2002077010A8 Method of preventing t-cell mediated responses by map proteins
11/13/2003WO2002074905A3 Leptin induced genes
11/13/2003WO2002074903A3 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
11/13/2003WO2002072888A3 Polymorphisms in the human cmoat gene and uses thereof
11/13/2003WO2002072770A3 Novel human proteins, polynucleotides encoding them and methods of using the same
11/13/2003WO2002070699A3 Cofactors of the estrogen receptor alpha and methods of use
11/13/2003WO2002070538A3 Narc8 programmed cell-death-associated molecules and uses thereof
11/13/2003WO2002069198A3 Hla ligand database utilizing predictive algorithms and methods of making and using same
11/13/2003WO2002066648A3 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
11/13/2003WO2002064831A3 Single nucelotide polymorphisms of the seek1 gene associated withpsoriasis
11/13/2003WO2002057779A8 Cloning and expression of a new mcp receptor in glial cells
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002057290A8 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/13/2003WO2002048339A3 Transgenic mice containing kir5.1 inwardly rectifying potassium channel gene disruptions
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002014362A3 A hepatitis c virus non-structural ns3/4a fusion gene
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003WO2000068248A8 Self assembling proteins
11/13/2003WO2000021978A3 Laminin 5, 13 and 14 and uses thereof
11/13/2003US20030213018 Comprises polypeptide coding cis-zeatin O-glucosyltransferase for increasing cytokinin production in plants; plant bioengineering for increased crop production
11/13/2003US20030213016 Cyclin D polynucleotides polypeptides and uses thereof
11/13/2003US20030213015 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase
11/13/2003US20030213014 Root transcriptional factors and methods of use
11/13/2003US20030213012 Pesticidal agents
11/13/2003US20030213006 Nucleotide sequences comprised of human chorionic gonadotropin (HCG) regulatory sequences for treating and preventing tumors via gene expression inhibition; drug screening
11/13/2003US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents
11/13/2003US20030213003 Preparing and recoverng genetically engineered fusion protein for treating diabetes
11/13/2003US20030212266 Growth arrest homeobox gene
11/13/2003US20030212265 Detection using genetic engineered nucleic acid
11/13/2003US20030212264 Pancreatic cancer genes
11/13/2003US20030212263 Mammastatin sequence variant C
11/13/2003US20030212260 Comprises nucleotide sequences coding fibroblast growth factor receptor activating gene 1 (FRAG1) for diagnosis and treatment of cancer; wound healing agents
11/13/2003US20030212259 Recombinant photoproteins and their conjugates
11/13/2003US20030212258 Comprises nucleotide sequences coding polypeptide for diagnosis, prevention and treatment of reproductive, inflammatory, nervous system and cancer disorders
11/13/2003US20030212257 Novel human proteins, polynucleotides encoding them and methods of using the same
11/13/2003US20030212256 Comprises a disintegrin and metalloprotease (ADAM) for use in prevention, diagnosis and treatment of cancer, cardiomyopathy and atherosclerosis
11/13/2003US20030212255 Novel proteins and nucleic acids encoding same
11/13/2003US20030212252 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
11/13/2003US20030212251 Synthesis of a potent parmagnetic agonist (epm-3) of the melanocyte stimulating hormone containing amino acid-type stable free radical
11/13/2003US20030212248 Using low molecular weight thiol compound such as cysteine, cysteamine, glutathione and 2-mercaptoethanol to stabilze solutions comprised of folded proteins
11/13/2003US20030212132 Determination binding of gabapentin to cells
11/13/2003US20030212025 Cd154 variants
11/13/2003US20030212001 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
11/13/2003US20030211997 Mimetic peptides for an epitope of apolipoprotein B-100, concatemers of the peptides, and modified peptides, and compositions comprising the same
11/13/2003US20030211996 Virus like particles
11/13/2003US20030211994 Composition and method for modulating vasculogenesis or angiogenesis
11/13/2003US20030211992 Method for treating cartilage disorders
11/13/2003US20030211991 Human sez6 nucleic acids and polypeptides
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211987 Dna libraries; genetic engineered nucleic acids
11/13/2003US20030211985 Binding to antibody; bactericides
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211981 Antidiabetic agents; vision disorders
11/13/2003US20030211977 Muscle relaxants; anticoagulants; cardiovascular disorders
11/13/2003US20030211972 Systemic administration of a therapeutic preparation
11/13/2003US20030211968 Neuromedin u receptor nmur2 and nucleotides encoding it
11/13/2003US20030211941 Plant cell membrane receptors; incubation culture; measuring variations in pH; purification
11/13/2003US20030211614 Using genetically engineered adeno-associated viral vector to transfer hereditary material into cells; gene therapy
11/13/2003US20030211613 Methods of altering calcium transport
11/13/2003US20030211598 Administering antitumor agents to tissues having an epithelial membrane; drug delivery; gene therapy
11/13/2003US20030211597 Genetically engineered hepatitis C viral (HVC) particle for use in prevention, diagnosis and prognostication of viral infections; immunoassays; genetic vaccines diagnosis
11/13/2003US20030211591 Separation of fibrinogen from plasma proteases
11/13/2003US20030211590 Fusion protein comprising cold shock domain and translocation sequences for delivery of nucleic acids into cell or nucleus in vitro and/or in situ; gene therapy; animal models
11/13/2003US20030211587 Keptin-a novel keratinocyte-specific proteinase inhibitor
11/13/2003US20030211581 Comprises nucleotide sequences coding genetic suppressor elements/transcription control elements; regulatory sequences; gene expresson inhibition
11/13/2003US20030211580 Comprises synthetic follicle stimulating hormone for increasing fertility, egg production and spermatogenesis
11/13/2003US20030211578 Comprises nucleotide sequences coding membrane protein for diagnosing and treating autoimmune diseases; drug screening
1 ... 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 ... 2916